Hostname: page-component-78c5997874-m6dg7 Total loading time: 0 Render date: 2024-11-11T07:10:28.812Z Has data issue: false hasContentIssue false

Cost-effectiveness of implementing national guidelines in the treatment of acute otitis media in children

Published online by Cambridge University Press:  19 September 2006

Hanna Koskinen
Affiliation:
Social Insurance Institution and National Research and Development Centre for Welfare and Health
Ulla-Maija Rautakorpi
Affiliation:
National Research and Development Centre for Welfare and Health
Harri Sintonen
Affiliation:
University of Helsinki and National Research and Development Centre for Welfare and Health
Pekka Honkanen
Affiliation:
Kemi Health Centre
Solja Huikko
Affiliation:
University of Tampere and National Public Health Institute
Pentti Huovinen
Affiliation:
National Public Health Institute
Timo Klaukka
Affiliation:
Social Insurance Institution
Erkki Palva
Affiliation:
National Agency for Medicines
Risto P. Roine
Affiliation:
Helsinki and Uusimaa Hospital District
Hannu Sarkkinen
Affiliation:
Päijät-Häme Central Hospital
Helena Varonen
Affiliation:
Finnish Institute of Occupational Health and Finnish Medical Society Duodecim
Marjukka Mäkelä
Affiliation:
National Research and Development Centre for Welfare and Health

Abstract

Objectives: Acute otitis media (AOM) is one of the most common diseases of childhood, representing a major disease burden on the society. New evidence-based guidelines for AOM, focusing on children under 7 years of age, were introduced in Finland in 1999. The aim of this study was to evaluate the cost-effectiveness of implementing those guidelines in Finland.

Methods: A 5-year prospective trial was conducted in thirty community primary healthcare centers in Finland. All AOM patients between 0 and 6 years of age visiting the study health centers for the first time, for this episode of illness, during 1 week in November 1998 (n = 579) and November 2002 (n = 369) were included in this study. The outcome measure was the percentage of symptom-free patients.

Results: The mean direct cost of an AOM episode per patient stayed almost the same after implementing the guidelines, €152 in 1998 and €150 in 2002. After implementing the guidelines, the percentage of symptom-free patients was 10 percentage points higher than before the guidelines. The treatment after the implementation of the guidelines, thus, was a dominant strategy.

Conclusions: Implementing the guidelines to the treatment of AOM in children was associated with extra health benefits at slightly lower direct costs and, thus, is a dominant strategy. The focus of this study was on the short-term effects of the treatment; including long-term effects in the analysis might affect the results.

Type
GENERAL ESSAYS
Copyright
© 2006 Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)